Home > Financial Ratios > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 39.1953.9668.0075.65-59.73

What is the latest Core EBITDA Growth ratio of KILITCH DRUGS (INDIA) ?

The latest Core EBITDA Growth ratio of KILITCH DRUGS (INDIA) is 39.19 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202439.19
Mar202353.96
Mar202268.00
Mar202175.65
Mar2020-59.73

How is Core EBITDA Growth of KILITCH DRUGS (INDIA) Trending?

Years Core EBITDA Growth % Change
Mar2024 39.19
-27.37
Mar2023 53.96
-20.65
Mar2022 68
-10.11
Mar2021 75.65
Positive
Mar2020 -59.73 -

Other Financial Ratios of KILITCH DRUGS (INDIA)


Compare Core EBITDA Growth ratio of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹756.4 Cr -3.7% -6.7% 36.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

-3.7%

-6.7%

36.6%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses